Drug Shortage Report for SANDOZ PROCTOMYXIN HC SUPPOSITORIES
| Report ID | 124304 |
| Drug Identification Number | 02242528 |
| Brand name | SANDOZ PROCTOMYXIN HC SUPPOSITORIES |
| Common or Proper name | SANDOZ PROCTOMYXIN HC SUPPOSITOIRES |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | DIBUCAINE HYDROCHLORIDE ESCULIN HYDROCORTISONE FRAMYCETIN SULFATE |
| Strength(s) | 5MG 10MG 5MG 10MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL RECTAL |
| Packaging size | 12SUP ST V1 CA |
| ATC code | C05AA |
| ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-09-11 |
| Estimated end date | 2020-10-16 |
| Actual end date | 2020-10-16 |
| Shortage status | Resolved |
| Updated date | 2020-10-19 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.